The FDA's controversial rejection of a skin cancer therapy from Replimune Group has prompted Krystal Biotech to shut down of ...

Soleno Therapeutics CEO responds to a 415-page short-seller report alleging safety issues tied to the company's newly ...

Correa and Bergman are co-chairs of the congressional Psychedelics Advancing Therapies (PATH) Caucus. Mercer is a Marine ...

Neuroscientists have long held that the brain reorganizes itself when a body part is amputated. A new study says that’s not ...

CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's proven effectiveness ...

The FDA has agreed to speed up a review of a rare disease drug developed by Stealth BioTherapeutics, a notable step after the company said it may have to close its doors otherwise.

Morning. Today, we see fallout from the FDA’s rejection of Replimune’s melanoma drug affecting another biotech, learn how Sarepta’s decision-making has affected a patient population that hasn’t always ...

Provide your payment details. The free trial associated with this subscription will be appended to the standard duration of ...

New additions introduced by Faulkner and others include an AI scribe powered by Microsoft to rival products from health tech ...

Good morning. We've got a meaty issue for you today. In particular, I urge you to spend some time with Jason Mast's story. It's another heartbreaking ...

After deaths and FDA setbacks, Sarepta abandoned LGMD gene therapy, leaving families desperate and patients without long-promised treatments.

But her body told another story. Her voice was flat. Her posture, rigid. Her hands trembled when she lifted her tea. She couldn’t sleep. She couldn’t concentrate. She kept scanning herself for signs ...